Department for Prevention and Care of Diabetes, Medical Clinic III, University Clinic Carl Gustav Carus at the Technical University Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany.
Nat Rev Endocrinol. 2012 Jan 17;8(6):363-73. doi: 10.1038/nrendo.2011.232.
During the past decade, improved understanding of the pathophysiological mechanisms of diabetes development has resulted in advances in therapeutic concepts, but has also supported the potential for diabetes prevention through nonpharmacological means. At the beginning of the century, we experienced a shift in paradigm, as landmark studies have shown that diabetes mellitus is preventable with lifestyle intervention; moderate changes in diet and physical activity produce a substantial and sustained reduction in the incidence of type 2 diabetes mellitus (T2DM) for individuals with impaired glucose tolerance. This evidence must now be translated into clinical and public-health practice, but translational studies have varied in their ability to replicate the results of clinical trials. This variation reflects a number of challenging barriers for diabetes prevention in real-world clinical practice, which makes it necessary to focus on identifying efficient intervention methods and delivery mechanisms. Research is now focusing on these mechanisms, as well as on developing efficient screening and risk-identification strategies and realistic scenarios for public-health policy to implement diabetes prevention programs. In this Review, we will discuss these mechanisms and will consider the implications of diabetes prevention for public-health strategy and policy.
在过去的十年中,对糖尿病发展病理生理机制的认识不断提高,推动了治疗理念的进步,也为非药物手段的糖尿病预防提供了可能。在本世纪初,我们经历了范式转变,因为一些重要的研究表明,通过生活方式干预可以预防糖尿病;饮食和身体活动的适度改变可显著且持续地降低糖耐量受损个体 2 型糖尿病(T2DM)的发病率。现在,必须将这些证据转化为临床和公共卫生实践,但转化研究在复制临床试验结果的能力方面存在差异。这种差异反映了在现实临床实践中进行糖尿病预防的许多具有挑战性的障碍,因此必须专注于确定有效的干预方法和实施机制。目前的研究重点是这些机制,以及开发有效的筛查和风险识别策略,以及为实施公共卫生政策制定现实场景。在这篇综述中,我们将讨论这些机制,并考虑糖尿病预防对公共卫生策略和政策的影响。